Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-896-9 | CAS number: 109089-77-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From June 5th, 2018 to June 20th, 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- 3-(2-methoxy-5-methylphenyl)-3-phenylpropanoic acid
- EC Number:
- 600-896-9
- Cas Number:
- 109089-77-2
- Molecular formula:
- C17H18O3
- IUPAC Name:
- 3-(2-methoxy-5-methylphenyl)-3-phenylpropanoic acid
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Six Sprague Dawley rats (SPF Caw) supplied by Elevage JANVIER LABS (53940 Le Genest St Isle – France)
- Females nulliparous and non-pregnant: yes
- Age at study initiation: At the beginning of the study, the animals were 8-week old, with a mean body weight of 195 g (SD: 2.9).
- Fasting period before study: yes
- Housing: Healthy female rats were housed by group of three in solid-bottomed clear polycarbonate cages with a stainless steel mesh lid. Each cage contains sawdust bedding which was changed at least 2 times a week. Each cage was installed in conventional air conditioned animal husbandry.
- Diet (e.g. ad libitum): standard laboratory foodstuff (ENVIGO 2016) ad libitum.
- Water (e.g. ad libitum): Tap water ad libitum.
- Acclimation period: at least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25ºC
- Humidity (%): 30-70%
- Air changes (per hr): at least 10 times/hour
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark.
IN-LIFE DATES: From: 05 June 2018 (step 1) & 06 June 2018 (step 2)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- DMSO
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 0.2 g/mL in stock solution.
- Justification for choice of vehicle: Dimethyl sulfoxide (DMSO) was chosen as it produced the most suitable formulation at the requested concentration.
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
DOSAGE PREPARATION: In the first and second step of the study, 2.0053 g and 2.0001 g of the test item were weighed and DMSO was added to two 10 mL volumetric flasks. Just before the administration, the preparations were stirred using a vortex to obtain yellowish solutions. Each preparation was administered under a volume of 10 mL/kg body weight using a suitable syringe graduated fitted with an oesophageal metal canula.
CLASS METHOD
- Rationale for the selection of the starting dose: As no information regarding the acute toxicity of the test item was available suggesting toxicity of the test item and in accordance with the principles of animal welfare, the first tested dose was 2000 mg/ kg b.w. - Doses:
- Step 1: 2000 mg/kg bw.
Step 2: 2000 mg/kg bw. - No. of animals per sex per dose:
- 3 female rats were used in step 1 (Rf2644, Rf2658, Rf2659) and 3 female rats in step 2 (Rf2649 to Rf2651)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Systematic examinations were carried out to identify any behavioural or toxic effects on the major physiological functions 30 min, 1h, 3h, 4h, 24h, 48h after administration of the test item and continued daily during 14 days. Weight was determined on day 0 (directly before administration), 2, 7 and 14 before euthanasia.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross examinations.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No treatment-related mortalities occurred during the study: one death (1/6) was noted in animals treated at the dose of 2000 mg/kg body weight on day 9. The mortality was preceded by dyspnea from day 2 to day 6 post dose, noisy breathing between days 7 and 9, swollen abdomen and piloerection on day 8 and a loss of body weight (-14% on day 2 and -29% on day 7). Rigor mortis and swollen abdomen were noted before the necropsy. The macroscopic examination of the animal revealed black spots on the corpus and air inside the digestive system. Thus, thiis death was due to a gavage injury.
- Clinical signs:
- other: In the surviving animal (5/6), no clinical signs related to the administration of the test item were observed during the study
- Gross pathology:
- The macroscopic examination of the animals at the end of the study did not reveal treatment related changes.
Any other information on results incl. tables
Table 1. Body weights and weight gain of the animals (grams)
FEMALES |
D0 |
D2 |
D2-D0 |
D7 |
D7-D0 |
D14 |
D14-D0 |
Rf 2644 Rf 2658 Rf 2659 |
208 195 188 |
226 212 160 |
18 17 -28 |
248 224 133 |
40 29 -55 |
273 243 |
65 48 |
† |
|
||||||
Rf 2649 Rf 2650 Rf 2651 |
208 201 189 |
203 222 238 |
-5 21 49 |
219 240 250 |
11 39 61 |
236 267 278 |
28 66 89 |
MEAN Standard deviation |
198.2 8.9 |
210.2 27.3 |
12.0 26.1 |
219.0 44.0 |
20.8 40.6 |
259.4 18.7 |
59.2 22.7 |
†: Animal Rf2659 found dead on D9
Table 2. Clinical signs, overall list.
Dose (mg/kg bw) |
Observation time |
Mortality |
Step 1. / Animal Rf. |
Step 2. / Animal Rf. |
||||
2644 |
2658 |
2659* |
2649 |
2650 |
2651 |
|||
2000 |
30min |
0 |
N |
N |
N |
N |
N |
N |
1h |
0 |
N |
N |
N |
N |
N |
N |
|
3h |
0 |
N |
N |
N |
N |
N |
N |
|
4h |
0 |
N |
N |
N |
N |
N |
N |
|
D1 |
0 |
N |
N |
N |
N |
N |
N |
|
D2-6 |
0 |
N |
N |
Dy |
N |
N |
N |
|
D7 |
0 |
N |
N |
N |
N |
N |
N |
|
D8 |
0 |
N |
N |
Pi |
N |
N |
N |
|
D9 |
1 |
N |
N |
- |
N |
N |
N |
|
D10-14 |
0 |
N |
N |
- |
N |
N |
N |
*Rf2659: wheezing on D2, noisy breathing on D7, noisy breathing and swollen stomach on D8, found dead on D9 (due to gavage injury).
Table 3. Necropsy findings, overall list.
Observations |
Step 1. / Animal Rf. |
Step 2. / Animal Rf. |
||||
2644 |
2658 |
2659* |
2649 |
2650 |
2651 |
|
General Appearance |
N |
N |
Rigor mortis, swollen abdomen |
N |
N |
N |
Oesophagus |
N |
N |
N |
N |
N |
N |
Stomach |
N |
N |
Black spot on the corpus |
N |
N |
N |
Duodenum |
N |
N |
presence of air inside the digestive system |
N |
N |
N |
Jejunum |
N |
N |
N |
N |
N |
N |
Ileon |
N |
N |
N |
N |
N |
N |
Caecum |
N |
N |
N |
N |
N |
N |
Colon |
N |
N |
N |
N |
N |
N |
Rectum |
N |
N |
N |
N |
N |
N |
Spleen |
N |
N |
N |
N |
N |
N |
Liver |
N |
N |
N |
N |
N |
N |
Thymus |
N |
N |
N |
N |
N |
N |
Trachea |
N |
N |
N |
N |
N |
N |
Lungs |
N |
N |
N |
N |
N |
N |
Heart |
N |
N |
N |
N |
N |
N |
Kidneys |
N |
N |
N |
N |
N |
N |
Urinary bladder |
N |
N |
N |
N |
N |
N |
Ovaries |
N |
N |
N |
N |
N |
N |
Uterus |
N |
N |
N |
N |
N |
N |
Treatment area |
N |
N |
N |
N |
N |
N |
Adrenals |
N |
N |
N |
N |
N |
N |
Pancreas |
N |
N |
N |
N |
N |
N |
Particulars |
|
|
bw: 118 g |
|
|
|
*Animal found dead on D9 due to gavage injury; N: Nothing to report.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- (EU criteria)
- Conclusions:
- The oral LD50 of the test item in female rats was greater thatn 2000 mg/kg bw. The LD50 cut-off of the test item may be considered to be higher than 5000 mg/kg bw.
- Executive summary:
The potential acute toxicity of the test item was studied on female Sprague-Dawley rats, according to OECD TG 423 and EU method B.1 tris, under GLP conditions. Since no data indicating acute toxicity was available, a first step was performed by administering a single dose of 2000 mg/kg bw test item to three animals by gavage. As no mortality was observed, a second step was performed by dosing three additional animals with the same dose. One death (1/6) was noted in the treated animals on day 9. However, the macroscopic examination of the animal revealed that it was due to a gavage injury. Therefore, no treatment-related mortality was observed in the study. In the surviving animals (5/6), no clinical signs related to the administration of the test item were observed during the study. The body weight evolution of the animals remained normal during the study. The macroscopic examination of the animals at the end of the study did not reveal treatment related changes. Based on the results, the oral LD50 was found to be > 2000 mg/kg bw. In accordance with the OECD TG 423, the LD50 cut-off of the test item may be considered to be higher than 5000 mg/ kg body weight by oral route in the rat.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.